Stem Cell Therapy Market Size to Lead USD 59.70 Billion by 2035

The stem cell therapy market size is expected to be worth USD 59.70 billion by 2035, increasing from USD 18.13 billion in 2025, with a strong CAGR of 12.66% from 2026 to 2035.

Ottawa, Feb. 25, 2026 (GLOBE NEWSWIRE) -- According to Precedence Research, the global stem cell therapy market size accounted for USD 18.13 billion in 2025 and is predicted to increase from USD 20.53 billion in 2026 to approximately USD 59.70 billion by 2035, expanding at a CAGR of 12.66% from 2026 to 2035. The growth is fuelled by massive research investments, a surge in chronic disease incidence, and advancements in regenerative medicine, especially in oncology and neurology.

The Complete Study is Now Available for Immediate Access | Download the Sample Pages of this Report@ https://www.precedenceresearch.com/sample/1989

Market Highlights:

North America held the largest market share of 54% in 2025.
The Asia Pacific region is projected to grow at a CAGR of 10% from 2026 to 2035.
The adult stem cells (ASCs) segment accounted for 86.1% of the revenue share in 2025.
The induced pluripotent stem cells (iPSCs) segment is expected to grow at a CAGR of 10% between 2026 and 2035.
The regenerative medicine application segment dominated with 93% market share in 2025.
The drug discovery and development application segment is forecasted to grow at a CAGR of 10.2% from 2026 to 2035.
The allogenic stem cell therapy segment held a market share of 59% in 2025.

What is a Stem Cell Therapy?

The stem cell therapy is a process that transplants healthy stem cells to regenerate, repair, or replace damaged or dysfunctional tissue. This therapy is used to treat chronic conditions like cancer, orthopedic injuries, and autoimmune disorders. The blood stem cell transplantation is the most established and regulatory board-approved treatment. This therapy has a potential application in treating neurodegenerative and neurological conditions.

Stem cell therapy is booming due to its superior potential for repairing damaged tissue, a surge in demand from the aging population, and notable investments in research. This market is further propelled by the rise in prevalence of chronic diseases and recent innovation in regenerative therapies.

➡️ Become a valued research partner with us ☎ https://www.precedenceresearch.com/schedule-meeting

Market Opportunity

Growing Expansion of CAR-T Cell Therapies

CAR-T cell therapies are experiencing immense growth due to their superior potency in treating blood cancer and their ability to remain in the body to prevent recurrence. Recent innovations like stem cell-derived CAR-T cells are improving safety, persistence, and accessibility. These target specific antigens due to their enhanced precision, minimizing damage to healthy cells. This therapy is rapidly expanding into autoimmune disease, solid tumors, and infectious disease.

This market is further expanded by various technological advancements like induced pluripotent stem cells (iPSCs) as an alternative to embryonic stem cells (ESCs). Remarkable investments from the private and government sectors in R&D alongside rapidly growing clinical trials are accelerating the innovation of new therapies, which is further boosting the market.

Built for leaders who move markets. Access live, actionable intelligence with Precedence Q. https://www.precedenceresearch.com/precedenceq/

The chart reveals that global interventional cell therapy trials peaked around 2021, followed by a period of stabilization through 2024. During this time, Phase I trials remained dominant, while Phase III and IV activities remained limited. This trend reflects a shift from rapid expansion to consolidation, rather than a decline in the field.

Beyond the chart’s trend, recent clinical data shows that cancer cell therapy development is entering a more selective and mature phase. As of June 2025, more than 6,400 interventional cancer cell therapy trials were registered globally, with over 3,000 unique products under investigation, according to a November 2025 analysis by Nature Reviews Drug Discovery. While CAR-T therapies continue to dominate the pipeline, the volume of their trials has started to fluctuate as developers prioritize optimization, manufacturing efficiency, and cost control over merely increasing trial numbers.

At the same time, diversification is accelerating. Stem cell therapies rebounded to 29 trials in 2024, returning to previous peak levels. Additionally, CAR-NK cells, cell-based cancer vaccines, and TIL therapies are gaining strategic importance, particularly for treating solid tumors. Regulatory milestones, such as the first approvals of TIL and TCR therapies in 2024, indicate that this phase of consolidation is leading to clinically validated and commercially viable treatment options.

Major Trends in the Stem Cell Therapy Market

In recent years, stem cells and exosomes have been transforming wound care by leveraging their regenerative properties to enhance healing and improve outcomes. Mesenchymal stem cells (MSCs), in particular, are being utilized in wound care for their ability to secrete growth factors that promote tissue regeneration.

Dermatology is another key area where stem cell therapies are gaining acceptance. Autologous epidermal stem cells can treat various skin conditions, including severe burns. Other dermatological applications of stem cell therapy include wound healing, skin manifestations, and the treatment of toxic blistering caused by autoimmune diseases.

CRISPR technology is also making waves in stem cell therapy, with its potential to precisely modify a cell's genetic code, offering significant advancements in disease treatment and prevention. While genetic modification of typical cells has already been achieved, altering undifferentiated stem cells could lead to the regeneration of entire systems, such as the immune system.

Stem cells are also being explored for the production of laboratory-grown meat, known as "clean meat." Traditional meat production for human consumption contributes significantly to global warming, and sustainably produced meat is becoming increasingly necessary to meet global environmental demands.

Get informed with deep-dive intelligence on AI’s market impact https://www.precedenceresearch.com/ai-precedence

Market Scope

Report Coverage	Details
Market Size in 2025	USD 18.13 Billion
Market Size in 2026	USD 20.53 Billion
Market Size by 2035	USD 59.70 Billion
Growth Rate from 2026 to 2035	CAGR of 12.66%
Largest Market	North America
Base Year	2025
Forecast Period	2026 to 2035
Segments Covered	Product, Therapy Type, Application, Technology, End User, and Region
Regions Covered	North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Access the Full Stem Cell Therapy Market Study @ https://www.precedenceresearch.com/stem-cell-therapy-market

Segmental Insights

Type Insights

Which Type of Segment Dominated the Stem Cell Therapy Market?

The allogeneic stem cell therapy segment held a dominant market share of approximately 59% in 2025. It is dominating this market due to its prepackaged availability, enabling immediate treatment for patients. This market is rapidly expanding due to its high reliability, cost-effectiveness, and ability to treat a wide range of chronic diseases. These premanufactured products ensure consistent quality, making them more viable and accessible compared to customized, patient-specific manufacturing. Technological advancements in gene editing of stem cells help to minimize the risk of rejection, thus improving safety and potency.

The autologous segment is expected to grow at the highest CAGR over the studied period. It is growing tremendously in the market due to its superior safety profile and reduction in immune rejection and graft-versus-host disease by using the patient's own cells. The key drivers of this market are the rise in demand for precision medicine and fewer regulatory obstacles. A rise in the incidence of cancer and other chronic diseases has accelerated its demand.

Application Insights

Which Application Dominated the Stem Cell Therapy Market?

The regenerative medicine segment dominated the stem cell therapy market with approximately 93% share in 2025 and is expected to be the fastest growing segment between 2026 and 2035. It is leading in this market, as it offers a remedial permanent solution for various chronic conditions. Its dominance is propelled by a high-potential, tailored, cell-based approach that repairs tissue function paired with significant investments, favorable regulatory approvals, and a surge in demand for tissue engineering.

The market is pivoting towards minimally invasive regenerative treatment for orthopedic conditions over traditional surgeries. Along with that, it also serves as a platform for drug discovery and disease modeling, further strengthening their market dominance.

End User Insights

Why did the Hospitals Segment Dominate the Stem Cell Therapy Market?

The hospitals segment held the largest revenue share in the stem cell therapy industry in 2025. It dominates the market due to its infrastructure, which is crucial for specialized expensive procedures, clinical trials, and treating complicated chronic diseases. This market is propelled by a high density of patient, skilled, trained professionals, making them a primary user. Massive investments in the healthcare ecosystem and government-supported research enhance the capabilities of hospitals providing these services. The increased success rate with stem cell therapies in hospitals has strengthened the credibility and driven high patient demand, which has further boosted this market.

You can place an order or ask any questions. Please feel free to contact us at sales@precedenceresearch.com | +1 804 441 9344

Regional Insights

What is the U.S. Stem Cell Therapy Market Size?

The U.S. stem cell therapy market size is valued at USD 6.75 billion in 2025 and is expected to reach USD 21.31 billion by 2035, growing at a CAGR of 12.18% from 2026 to 2035.

Note: This report is readily available for immediate delivery. We can review it with you in a meeting to ensure data reliability and quality for decision-making.

Try Before You Buy – Get the Sample Report@ https://www.precedenceresearch.com/sample/1989

Why is North America Leading the Stem Cell Therapy Market?

North America is leading the stem cell therapy market with a 54% share in 2025. It leads this market due to its strong and well-established healthcare infrastructure, massive R&D investments, and a proactive regulatory environment. This market is driven by a surge in demand for regenerative medicine, the massive presence of major biotechnological firms, and the rapid commercialization of CAR-T and other cell therapies. This region also possesses robust research institutions, massive healthcare expenditure, and significant funding from both the government and the private sector.

The large patient population is paired with heightened awareness of stem cell application. The market is further expanded by the surge of precision medicine and advancement in induced pluripotent stem cells.

How Will Asia Pacific Grow in the Stem Cell Therapy Market?

Asia Pacific is experiencing the fastest growth in the market during the forecast period. It is witnessing significant growth due to favorable government support, a surge in investment in biotechnology, an increase in the incidence of chronic disease, and advancements in regenerative medicine. The market is further propelled by a surge in patient demand, strong clinical research, and a supportive ecosystem for innovation. Massive funding from biotech and pharmaceutical companies, along with government investments, has fueled this market. This market is further expanding in this region due to a rise in public awareness and a surge in healthcare expenditure.

Why Europe Saw Steady Growth in the Stem Cell Therapy Market

Europe's steady growth in the stem cell therapy market can be attributed to several factors, including stringent quality regulations, robust research funding, and increasing awareness of regenerative medicine. The establishment of a clinical trial system for treating rare diseases, heart repair, and joint diseases also contributed to this growth. Additionally, two major sources of opportunity played a crucial role: the rising elderly population and the growing prevalence of chronic diseases, which created a demand for regulated, safe, and affordable treatment options.

Germany's Stem Cell Therapy Market Trends

Germany is a leader in the European stem cell therapy market due to its extensive research laboratories, world-class universities, and well-defined safety guidelines. Stem cell therapies are being used for bone repair, neurological disorders, and autoimmune conditions. The country has received significant funding from both public and private sectors, enabling the expansion of clinical trials and enhancing patient awareness of stem cell therapies.

Why Latin America Saw Steady Growth in the Stem Cell Therapy Market

Latin America has experienced significant growth in the stem cell therapy market due to several key factors: the rise in medical tourism, lower treatment costs, and the growing number of private clinical research facilities. Additionally, the expanding middle class, increased healthcare spending, and the development of research and development facilities in the region have all contributed to making Latin America a growing market for affordable regenerative medicine.

Brazil's Stem Cell Therapy Market Trends

Brazil leads the Latin American stem cell therapy market, driven by reduced healthcare costs, government funding for research, and increased patient demand for stem cell therapies. The country has developed a range of applications for contemporary stem cell treatments, including for cardiovascular conditions, orthopedic issues, and age-related conditions. Local research facilities have continued to receive substantial funding, enhancing their ability to provide stem cell treatments to Brazilian patients.

Why the Middle East & Africa Saw Steady Growth in the Stem Cell Therapy Market

The Middle East and Africa have seen steady growth in the stem cell therapy market due to government investments in advanced treatment centers and the modernization of healthcare. Countries in the region have built new hospitals and formed partnerships with global biotech companies. There has also been a surge in demand for stem cell therapies for conditions such as diabetes, orthopedic injuries, and cosmetic treatments. The rising income levels and growing medical tourism have also created new opportunities for the introduction and expansion of stem cell therapies.

The UAE Stem Cell Therapy Market Trends

The United Arab Emirates (UAE) is the regional leader in terms of access to advanced regenerative medicine and treatments. The UAE government has made significant investments in building modern medical clinics and state-of-the-art laboratory facilities. Stem cell therapy in the UAE is being used to treat a wide range of conditions, including sports injuries, chronic diseases, and cosmetic concerns. These factors have also fueled the growth of medical tourism in the UAE.

In addition to these investments, the UAE government has supported the development of new clinical trials for stem cell therapy and the advancement of laboratory technologies, further enhancing the country's position in the market.

✚ Related Topics You May Find Useful:

➡️ Personalized Cell Therapy Market: Explore advancements in customized treatments for improved patient outcomes

➡️ Cell Therapy Manufacturing Market: Understand the evolving landscape of production and scalability

➡️ US Stem Cell Therapy Market: Discover the growth potential and applications of stem cell treatments in the US

➡️ Allogeneic Cell Therapy Devices Market: Analyze the impact of donor-derived treatments and innovative devices

➡️ T-Cell Therapy Market: Investigate the role of T-cell therapies in cancer treatment and beyond

➡️ Autologous Cell Therapy Market: Dive into the advantages and challenges of patient-derived therapies

➡️ Automated and Closed Cell Therapy Market: Track automation trends driving efficiency in cell therapy

➡️ Automated and Closed Cell Therapy Processing System Market: Examine technological innovations in cell processing

➡️ CAR-T Cell Therapy Market: Assess the potential of CAR-T therapies in transforming cancer treatments

➡️ Cell Therapy Market: Gain insights into the rapid growth and future prospects of cell-based therapies

Competitive Landscape

Caladrius
CELGENE CORPORATION
ReNeuron Group plc
Virgin Health Bank
Opexa Therapeutics, Inc.
Pluristem Therapeutics Inc
STEMCELL Technologies Inc.
Biovault family
Precious Cells International Ltd
Mesoblast Ltd
Seneca Biopharmaceuticals, Inc.

Recent Developments

In February 2026, Pluristyx and Solesis launched the PluriForm™-GFP-3D Transfection Kit. It is designed to overcome the challenges of transfecting pluripotent cells in 3D culture, including cells, synthetic mRNA, and reagents in a thaw-and-use configuration.
In January 2025, Medexus announced that the FDA had approved GRAFAPEX, a regimen for allogeneic hematopoietic stem cell transplantation in adults and pediatric patients aged one year and older with acute myeloid leukemia or myelodysplastic syndrome.

Segments Covered in the Report

By Product

Adult Stem Cells (ASCs)
- Hematopoietic
- Mesenchymal
- Neural
- Epithelial/Skin
- Others
Human Embryonic Stem Cells (HESCs)
Induced Pluripotent Stem Cells (iPSCs)
Very Small Embryonic Like Stem Cells

By Therapy Type

Autologous
Allogenic

By Application

Regenerative Medicine
- Neurology
- Orthopedics
- Oncology
- Hematology
- Cardiovascular and Myocardial Infraction
- Injuries
- Diabetes
- Liver Disorder
- Incontinence
- Others
Drug Discovery and Development

By Technology

Cell Acquiition
- Bone Marrow Harvest
- Umbilical Blood Cord
- Apheresis
Cell Production
- Therapeutic Cloning
- In-vitro Fertilization
- Cell Culture
- Isolation
Cryopreservation
Expansion and Sub-Culture

By End User

Hospitals
Research institutes
surgical institutes
Orders

By Region

North America
Latin America
Europe
Asia-pacific
Middle and East Africa

Thank you for reading. You can also get individual chapter-wise sections or region-wise report versions, such as North America, Europe, or Asia Pacific.

Immediate Delivery Available | Buy This Premium Research Report@ https://www.precedenceresearch.com/checkout/1989

You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 804 441 9344

Stay Ahead with Precedence Research Subscriptions

Unlock exclusive access to powerful market intelligence, real-time data, and forward-looking insights, tailored to your business. From trend tracking to competitive analysis, our subscription plans keep you informed, agile, and ahead of the curve.

Browse Our Subscription Plans@ https://www.precedenceresearch.com/get-a-subscription

About Us

Precedence Research is a worldwide market research and consulting organization. We give an unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.

Web: https://www.precedenceresearch.com

Our Trusted Data Partners:

Get Recent News:

https://www.precedenceresearch.com/news

For the Latest Update Follow Us:

LinkedIn | Medium | Facebook | Twitter

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.